Edition:
India

Argos Therapeutics Inc (ARGS.OQ)

ARGS.OQ on NASDAQ Stock Exchange Capital Market

1.07USD
18 Apr 2018
Change (% chg)

-- (--)
Prev Close
$1.07
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
119,465
52-wk High
$16.21
52-wk Low
$0.70

Chart for

About

Argos Therapeutics, Inc. (Argos) is an immuno-oncology company. The Company is focused on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its technology platform called Arcelis. The Company's Arcelis technology platform utilizes biological... (more)

Overall

Beta: 1.34
Market Cap(Mil.): $9.79
Shares Outstanding(Mil.): 54.97
Dividend: --
Yield (%): --

Financials

  ARGS.OQ Industry Sector
P/E (TTM): -- 30.95 32.74
EPS (TTM): -1.61 -- --
ROI: -200.62 14.84 14.38
ROE: -- 16.34 16.07

BRIEF-Argos Therapeutics Reports Q4 Loss Per Share $0.38

* ARGOS THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

02 Apr 2018

REFILE-BRIEF-Argos Therapeutics' Cash And Cash Equivalents About $15.2 Mln At Year End

* ARGOS THERAPEUTICS INC SAYS ESTIMATES THAT ITS CASH AND CASH EQUIVALENTS AS OF DEC 31, 2017 WERE ABOUT $15.2 MILLION

08 Mar 2018

BRIEF-Argos Obtains Option To License PD1 Checkpoint Inhibitors

* ARGOS THERAPEUTICS INC - ENTERED INTO AN OPTION AGREEMENT WITH PHARMSTANDARD INTERNATIONAL, S.A. AND ACTIGEN LIMITED

06 Feb 2018

BRIEF-Argos Therapeutics Board Approves One-For-Twenty Reverse Split Of Co's Common Stock Effective Jan 18, After Close

* ARGOS THERAPEUTICS - BOARD APPROVED ONE-FOR-TWENTY REVERSE SPLIT OF CO'S COMMON STOCK THAT WILL TAKE EFFECT JANUARY 18, AFTER CLOSE OF TRADING Source text for Eikon: Further company coverage:

18 Jan 2018

BRIEF-Argos Announces $1.5 Million Equity Investment By Lummy (Hong Kong) Ltd

* ARGOS ANNOUNCES $1.5 MILLION EQUITY INVESTMENT BY LUMMY (HONG KONG), LTD. Source text for Eikon: Further company coverage:

08 Jan 2018

BRIEF-Argos Therapeutics Enters Into Agreement With Saint-Gobain Performance Plastics Corp

* ARGOS THERAPEUTICS - ‍ON NOV 22, ENTERED INTO A SATISFACTION AND RELEASE AGREEMENT WITH SAINT-GOBAIN PERFORMANCE PLASTICS CORP - SEC FILING

28 Nov 2017

BRIEF-Argos Provides Financial Update

* ARGOS THERAPEUTICS - ‍TKC PROPERTIES HAS, WITH ARGOS' FULL CONSENT, SUCCESSFULLY COMPLETED SALE OF FACILITY IN DURHAM COUNTY, NC TO A THIRD PARTY​

28 Nov 2017

BRIEF-Argos reports third quarter financial results

* Argos reports third quarter 2017 financial results and operational highlights

10 Nov 2017

BRIEF-Argos Therapeutics files for offering of 13.5 mln shares of common stock by Invetech

* Argos Therapeutics files for offering of 13.5 million shares of common stock by Invetech Pty Ltd - SEC filing Source text: (http://bit.ly/2zcHDkV) Further company coverage:

04 Nov 2017

Earnings vs. Estimates